Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
40.30
-0.59 (-1.44%)
Jul 25, 2025, 3:04 PM CST
SHE:002773 Revenue
Chengdu Kanghong Pharmaceutical Group had revenue of 1.20B CNY in the quarter ending March 31, 2025, with 9.70% growth. This brings the company's revenue in the last twelve months to 4.56B, up 9.44% year-over-year. In the year 2024, Chengdu Kanghong Pharmaceutical Group had annual revenue of 4.45B with 12.51% growth.
Revenue (ttm)
4.56B
Revenue Growth
+9.44%
P/S Ratio
8.14
Revenue / Employee
1.02M
Employees
4,462
Market Cap
37.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.45B | 495.20M | 12.51% |
Dec 31, 2023 | 3.96B | 568.43M | 16.77% |
Jan 1, 2023 | 3.39B | -216.32M | -6.00% |
Jan 1, 2022 | 3.61B | 309.92M | 9.40% |
Dec 31, 2020 | 3.30B | 38.00M | 1.17% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |